한빛사논문
Minsuk Kwak1,2,3,4,5,6,18, Kaden M. Southard1,2,18, Woon Ryoung Kim1,2,3,18, Annie Lin1,2,3, Nam Hyeong Kim1,2,3,6,7,8, Ramu Gopalappa4,9, Hyun Jung Lee1,2,3, Minji An4,5, Seo Hyun Choi4,5, Yunmin Jung4,5, Kunwoo Noh4,5, Justin Farlow2, Anastasios Georgakopoulos10, Nikolaos K. Robakis10, Min K. Kang11, Matthew L. Kutys12, Daeha Seo13, Hyongbum Henry Kim4,5,9,14,15, Yong Ho Kim6,7,8, Jinwoo Cheon4,5,16, Zev J. Gartner2,17 & Young-wook Jun1,2,3,4,5
1Department of Otolaryngology, University of California, San Francisco, CA, USA.
2Department of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA.
3Helen Diller Family Cancer Comprehensive Center (HDFCCC), University of California, San Francisco, CA, USA.
4Center for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea.
5Graduate Program of Nano Biomedical Engineering (Nano BME), Advanced Science Institute, Yonsei University, Seoul, Republic of Korea.
6SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University, Suwon, Republic of Korea.
7Department of Nano Engineering, Sungkyunkwan University, Suwon, Republic of Korea.
8Imnewrun Inc., Suwon, Republic of Korea.
9Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.
10Department of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
11Department of Neurology, University of California, San Francisco, CA, USA.
12Department of Cell and Tissue Biology, University of California, San Francisco, CA, USA.
13Department of Physics and Chemistry, DGIST, Daegu, Republic of Korea.
14Brain Korea 21 Plus Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
15Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
16Department of Chemistry, Yonsei University, Seoul, Republic of Korea.
17Chan Zuckerberg Biohub, San Francisco, CA, USA.
18These authors contributed equally: Minsuk Kwak, Kaden M. Southard, Woon Ryoung Kim
Correspondence and requests for materials should be addressed to Zev J. Gartner or Young-wook Jun
Abstract
Adherens junctions (AJs) create spatially, chemically and mechanically discrete microdomains at cellular interfaces. Here, using a mechanogenetic platform that generates artificial AJs with controlled protein localization, clustering and mechanical loading, we find that AJs also organize proteolytic hotspots for γ-secretase with a spatially regulated substrate selectivity that is critical in the processing of Notch and other transmembrane proteins. Membrane microdomains outside of AJs exclusively organize Notch ligand-receptor engagement (LRE microdomains) to initiate receptor activation. Conversely, membrane microdomains within AJs exclusively serve to coordinate regulated intramembrane proteolysis (RIP microdomains). They do so by concentrating γ-secretase and primed receptors while excluding full-length Notch. AJs induce these functionally distinct microdomains by means of lipid-dependent γ-secretase recruitment and size-dependent protein segregation. By excluding full-length Notch from RIP microdomains, AJs prevent inappropriate enzyme-substrate interactions and suppress spurious Notch activation. Ligand-induced ectodomain shedding eliminates size-dependent segregation, releasing Notch to translocate into AJs for processing by γ-secretase. This mechanism directs radial differentiation of ventricular zone-neural progenitor cells in vivo and more broadly regulates the proteolysis of other large cell-surface receptors such as amyloid precursor protein. These findings suggest an unprecedented role of AJs in creating size-selective spatial switches that choreograph γ-secretase processing of multiple transmembrane proteins regulating development, homeostasis and disease.
논문정보
관련 링크
연구자 키워드
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기